Hong Guo-Parke

1.7k total citations
30 papers, 628 citations indexed

About

Hong Guo-Parke is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Hong Guo-Parke has authored 30 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Hong Guo-Parke's work include Respiratory viral infections research (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Neonatal Respiratory Health Research (5 papers). Hong Guo-Parke is often cited by papers focused on Respiratory viral infections research (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Neonatal Respiratory Health Research (5 papers). Hong Guo-Parke collaborates with scholars based in United Kingdom, China and United States. Hong Guo-Parke's co-authors include Peter R. Flatt, Neville H. McClenaghan, Jane T. McCluskey, Clifford C. Taggart, Dermot Linden, Muhajir Hamid, Peter Coyle, Ramón Gomis, Catriona Kelly and Ultan F. Power and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Hong Guo-Parke

28 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Guo-Parke United Kingdom 13 221 194 178 156 115 30 628
Charu Rajput United States 19 148 0.7× 124 0.6× 151 0.8× 156 1.0× 48 0.4× 29 710
Bjarki Jóhannesson United States 12 160 0.7× 209 1.1× 418 2.3× 23 0.1× 138 1.2× 12 792
Sara Reiss United States 13 77 0.3× 138 0.7× 126 0.7× 68 0.4× 34 0.3× 19 510
Alaina L. Garland United States 13 74 0.3× 208 1.1× 113 0.6× 43 0.3× 131 1.1× 15 516
Amado A. Quintar Argentina 14 39 0.2× 148 0.8× 146 0.8× 62 0.4× 33 0.3× 30 571
Yaneisi Vázquez Chile 9 41 0.2× 66 0.3× 158 0.9× 98 0.6× 42 0.4× 11 402
Tomomi Yoshitomi Japan 11 91 0.4× 66 0.3× 122 0.7× 116 0.7× 15 0.1× 20 516
Kensuke Hirasawa Netherlands 15 178 0.8× 90 0.5× 147 0.8× 184 1.2× 222 1.9× 57 795
F. L. Munro Canada 6 75 0.3× 187 1.0× 262 1.5× 57 0.4× 41 0.4× 6 630
Amarjit Mishra United States 15 57 0.3× 157 0.8× 209 1.2× 67 0.4× 27 0.2× 35 592

Countries citing papers authored by Hong Guo-Parke

Since Specialization
Citations

This map shows the geographic impact of Hong Guo-Parke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Guo-Parke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Guo-Parke more than expected).

Fields of papers citing papers by Hong Guo-Parke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Guo-Parke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Guo-Parke. The network helps show where Hong Guo-Parke may publish in the future.

Co-authorship network of co-authors of Hong Guo-Parke

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Guo-Parke. A scholar is included among the top collaborators of Hong Guo-Parke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Guo-Parke. Hong Guo-Parke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chuang, Betül Tosun, Pei Wang, et al.. (2025). Psychometric evaluation of the Chinese version of the BENEFITS-CCCSAT based on CTT and IRT: a cross-sectional design translation and validation study. Frontiers in Public Health. 13. 1532709–1532709. 2 indexed citations
3.
4.
Linden, Dermot, Hong Guo-Parke, G.G. Einarsson, et al.. (2023). Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD. CHEST Journal. 164(3). 625–636. 2 indexed citations
5.
Su, Xiaojie, Ting Lei, Lu Zhang, et al.. (2023). NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis. International Journal of COPD. Volume 18. 811–825. 17 indexed citations
6.
Lei, Ting, et al.. (2023). Efficacy and safety of three species of Rhodiola L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1139239–1139239. 2 indexed citations
7.
Guo-Parke, Hong, Aoife M. Rodgers, Dermot Linden, et al.. (2023). Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis. Biomedicines. 11(7). 2072–2072. 11 indexed citations
8.
Bailey, Melanie J., Dermot Linden, Hong Guo-Parke, et al.. (2023). Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system. Frontiers in Medicine. 10. 1208866–1208866. 4 indexed citations
9.
Guo-Parke, Hong, Dermot Linden, Aurélie Mousnier, et al.. (2022). Altered Differentiation and Inflammation Profiles Contribute to Enhanced Innate Responses in Severe COPD Epithelium to Rhinovirus Infection. Frontiers in Medicine. 9. 741989–741989. 4 indexed citations
10.
Broadbent, Lindsay, Hong Guo-Parke, Andrena Millar, et al.. (2019). Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures. Antimicrobial Agents and Chemotherapy. 64(2). 15 indexed citations
11.
Peng, Lei, Hong Guo-Parke, Peilin Ma, et al.. (2019). HoxA9 binds and represses the Cebpa +8 kb enhancer. PLoS ONE. 14(5). e0217604–e0217604. 4 indexed citations
13.
Broadbent, Lindsay, Rémi Villenave, Hong Guo-Parke, et al.. (2016). In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs). Methods in molecular biology. 1442. 119–139. 17 indexed citations
15.
Patterson, Steven, Nigel Irwin, Hong Guo-Parke, et al.. (2015). Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells. European Journal of Pharmacology. 771. 107–113. 12 indexed citations
16.
Guo-Parke, Hong, Paul Canning, Isobel Douglas, et al.. (2013). Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium. American Journal of Respiratory and Critical Care Medicine. 188(7). 842–851. 75 indexed citations
17.
McCluskey, Jane T., Muhajir Hamid, Hong Guo-Parke, et al.. (2011). Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion. Journal of Biological Chemistry. 286(25). 21982–21992. 115 indexed citations
18.
Kelly, Catriona, Hong Guo-Parke, Jane T. McCluskey, Peter R. Flatt, & Neville H. McClenaghan. (2010). The role of glucagon‐ and somatostatin‐secreting cells in the regulation of insulin release and beta‐cell function in heterotypic pseudoislets. Diabetes/Metabolism Research and Reviews. 26(7). 525–533. 25 indexed citations
19.
Kelly, Catriona, Hong Guo-Parke, Jane T. McCluskey, Peter R. Flatt, & Neville H. McClenaghan. (2010). Comparison of Insulin Release From MIN6 Pseudoislets and Pancreatic Islets of Langerhans Reveals Importance of Homotypic Cell Interactions. Pancreas. 39(7). 1016–1023. 37 indexed citations
20.
Zhang, Ke, Chun Ye, Qin Zhou, et al.. (2007). PKD1 inhibits cancer cells migration and invasion via Wnt signaling pathway in vitro. Cell Biochemistry and Function. 25(6). 767–774. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026